
Lupin Limited has informed the Exchange regarding a press release dated January 23, 2024, titled "Lupin Receives Tentative Approval from U.S. FDA for Rivaroxaban Tablets USP.".
Filed with NSE ·

Lupin Limited has informed the Exchange regarding a press release dated January 23, 2024, titled "Lupin Receives Tentative Approval from U.S. FDA for Rivaroxaban Tablets USP.".
6ix hasn’t read this filing yet.
Follow Lupin into a list and get an email when it puts out news.
Follow Lupin